Fertility preservation in cancer patients

Women's Health

Volumn 2, Issue 3, 2006, Pages 479-489

  Bedaiwy, Mohamed A ^a   Falcone, Tommaso ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Fertility preservation; Oocyte and ovarian tissue cryopreservation; Premature ovarian failure

Indexed keywords

AROMATASE INHIBITOR; BLEOMYCIN; CARBOPLATIN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FLUOROURACIL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; GONADOTROPIN; LETROZOLE; MELPHALAN; METHOTREXATE; ORAL CONTRACEPTIVE AGENT; PROCARBAZINE; PROGESTERONE; SPHINGOSINE 1 PHOSPHATE; STEROID; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CHEMOPROPHYLAXIS; CRYOPRESERVATION; FEMALE; FEMALE FERTILITY; FERTILIZATION IN VITRO; GAMETE; GONAD; HUMAN; LAPAROSCOPY; OVARY; PARTHENOGENESIS; PREMATURE OVARIAN FAILURE; RADIATION FIELD; RADIATION PROTECTION; REPRODUCTION; REPRODUCTIVE TOXICITY; REVIEW; STORAGE; SURGICAL TECHNIQUE; THERAPY DELAY; TISSUE PRESERVATION; TISSUE TRANSPLANTATION; UTERUS DISEASE; UTERUS GROWTH;

EID: 33646770356     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.2.3.479     Document Type: Review

References (67)

1. Johnson J, Canning J, Kaneko T, Pru JK. Tilly JL: Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428, 145-150 (2004).
2. Green DM, Whitton JA, Stovall M et al: Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am. J Obstet. Gynecol. 187, 100-1080 (2002).
3. Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugieres L, Jouannet P: Human ovarian tissue cryopreservation: indications and feasibility. Hum. Reprod. 17, 1447-1452 (2002)
4. Waggoner SE: Cervical cancer. Lancet 361, 2217-2225 (2003).
5. Weir HK, Thun MJ, Hankey BF et al.: Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J. Natl Cancer Inst. 95, 1276-1299 (2003).
6. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J. Clin. 53, 5-26 (2003).
7. Bath LE, Tydeman G, Critchley HO, Anderson RA, Baird DT, Wallace WH: Spontaneous conception in a young woman who had ovarian cortical tissue cryopreserved before chemotherapy and radiotherapy for a Ewing's sarcoma of the pelvis: case report. Hum. Reprod. 19. 2569-2572 (2004).
8. Smitz J, Cortvrindt R: First childbirth from transplanted cryopreserved ovarian tissue brings hope for cancer survivors. Lancet 364, 1379-1380 (2004).
9. Schilsky RL, Sherins RJ, Hubbard SM, Wesley MN, Young RC, DeVita VT: Longterm follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am. J. Med. 71, 552-556 (1981).
10. Multidisciplinary Working Group convened by the British Fertility Society: MWGcbt: a strategy for fertility services for survivors of childhood cancer. Hum. Fertil. 6, A1-A40 (2003).
11. Meirow D, Schenker JG, Rosier A: Ovarian hyperstimulation syndrome with low oestradiol in nonclassical 17 alpha-hydroxylase, 17,20-lyase deficiency: what is the role of oestrogens? Hum. Reprod. 11, 2119-2121 (1996).
12. Meirow D, Nugent D: The effects of radiotherapy and chemotherapy on female reproduction. Hum. Reprod. Update 7, 535-543 (2001).
13. Gosden RG, Wade JC, Fraser HM, Sandow J, Faddy MJ: Impact of congenital or experimental hypogonaclotrophism on the radiation sensitivity of the mouse ovary. Hum. Reprod. 12, 2483-2488 (1997).
14. Husseinzadeh N, Nahhas WA, Velkley DE, Whitney CW, Mortel R: The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol. Oncol. 18, 373-379 (1984).
15. Wallace WH, Thomson AB, Kelsey TW: The radiosensitivity of the human oocyte. Hum. Reprod. 18, 117-121 (2003).
16. Williams RS, Littell RD, Mendenhall NP: Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer 86, 2138-2142 (1999).
17. Critchley HO, Bath LE. Wallace WH: Radiation damage to the uterus - review of the effects of treatment of childhood cancer. Hum. Fertil. (Camb.) 5, 61-66 (2002).
18. Bath LE, Wallace WH, Critchley HO: Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. Br. J. Obstet. Gynaecol. 109, 107-114 (2002).
19. Emery S, Falcone T. Pregnancy after cancer treatment. In: Preservation of Fertility. Tulandi T, Gosden RG (Eds). Taylor & Francis Medical books, Abingdon, Oxon, UK, 217-224 (2004).
20. Crofton PM, Thomson AB, Evans AE et al.: Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer? Clin. Endocrinal. (Oxf.) 58, 296-301 (2003).
21. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA: Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone. inhibin B and ovarian ultrasound. Hum. Reprod. 18, 2368-2374 (2003).
22. Ruess ML, Kline J, Santos R, Levin B, Timor-Tritsch I: Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am. J. Obstet. Gynecol. 174, 624-627 (1996).
23. Son WY, Yoon SH, Yoon HJ, Lee SM, Lim JH: Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum. Reprod. 18, 137-139 (2003).
24. Assisted reproductive technology in the United States: (1998) results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil. Steril. 77, 18-31 (2002).
25. Meniru GI, Craft I: In vitro fertilization and embryo cryopreservation prior to hysterectomy for cervical cancer. Int. J. Gynaecol. Obstet. 56, 69-70 (1997).
26. Pelinck MJ, Hoek A, Simons AH. Heineman MJ: Efficacy of natural cycle IVF: a review of the literature. Hum. Reprod. Update 8, 129-139 (2002).
27. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z: Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum. Reprod. 18, 90-95 (2003).
28. Oktay K, Buyuk E. Akar Z, Rosenwaks N, Libertella N: Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Fertil. Steril. 82, S1 (2004) (Abstract).
29. Oktay K: Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J. Clin. Oncol. 23, 3858-3859 (2005).
30. Stachecki JJ, Cohen J, Willadsen S: Detrimental effects of sodium during mouse oocyte cryopreservation. Biol. Reprod. 59, 395-400 (1998).
31. Katayama KP, Stehlik J, Kuwayama M, Kato O, Stehlik E: High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil. Steril. 80, 223-224 (2003).
32. Liebermann J, Tucker MJ, Sills ES: Cryoloop vitrification in assisted reproduction: analysis of survival rates in > 1000 human oocytes after ultrarapid cooling with polymer augmented cryoprotectants. Clin. Exp. Obstet. Gynecol. 30, 125-129 (2003).
33. Yoon TK, Kim TJ, Park SE et al.: Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transer program. Fertil. Steril. 79, 1323-1326 (2003).
34. Porcu E, Fabbri R, Damiano G, Fratto R, Giunchi S, Venturoli S: Oocyte cryopreservation in oncological patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 113(Suppl. 1), S14-S16 (2004).
35. Practice Committee of the American Society for Reproductive Medicine: Ovarian tissue and oocyte cryopreservation. Fertil. Steril. 82, 993-998 (2004).
36. Gosden RG, Baird DT, Wade JC, Webb R: Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum. Reprod. 9, 597-603 (1994).
37. Baird DT, Webb R, Campbell BK, Harkness LM, Gosden RG: Long-term ovarian function in sheep after ovariectomy and trans-plantation of autografts stored at -196°C. Endocrinology 140, 462-471 (1999).
38. Oktay K, Buyuk E: The potential of ovarian tissue transplant to preserve fertility. Expert Opin. Biol. Ther. 2, 361-370 (2002).
39. Rao GD, Chian RC, Son WS, Gilbert L, Tan SL: Fertility preservation in women undergoing cancer treatment. Lancet 363, 1829-1830 (2004).
40. Sonmezer M, Oktay K: Fertility preservation in female patients. Hum. Reprod. Update 10, 251-266 (2004).
41. Oktay K, Buyuk E, Veeck L et al: Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363, 837-840 (2004).
42. Donnez J, Dolmans MM, Demylle D et al.: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364, 1405-1410 (2004).
43. Meirow D. Levron J, Eldar-Geva T et al.: Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N. Engl. J. Med. 353, 318-321 (2005).
44. Silber SJ, Lenahan KM, Levine DJ et al: Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N. Engl. J. Med. 353, 58-63 (2005).
45. Aubard Y: Ovarian tissue graft: from animal experiment to practice in the human. Eur. J. Obstet. Gynecol. Reprod. Biol. 86, 1-3 (1999).
46. Wang X, Chen H, Yin H, Kim SS, Lin Tan S, Gosden RG: Fertility after intact ovary transplantation. Nature 415, 385 (2002).
47. Jeremias E, Bedaiwy MA, Gurunluoglu R, Biscotti CV, Siemionow M, Falcone T: Heterotopic autotransplantation of the ovary with microvascular anastomosis: a novel surgical technique. Fertil. Steril. 77, 1278-1282 (2002).
48. Bedaiwy MA, Jeremias E, Gurunluoglu R et al.: Restoration of ovarian function after autotransplantation of intact frozen-thawed sheep ovaries with microvascular anastomosis. Fertil. Steril. 79, 594-602 (2003).
49. Gook DA, Edgar DH, Borg J, Archer J, Lutjen PJ, McBain JC: Oocyte maturation, follicle rupture and luteinization in human cryopreserved ovarian tissue following xenografting. Hum. Reprod. 18, 1772,-1781 (2003).
50. Howell SJ, Shalet SM: Fertility preservation and management of gonadal failure associated with lymphoma therapy. Curr. Oncol. Rep. 4, 443-452 (2002).
51. Hadar H, Loven D, Herskovitz P. Bairey O, Yagoda A, Levavi H: An evaluation of lateral and medial transposition of the ovaries out of radiation fields. Cancer 74, 774-779 (1994).
52. Howard FM: Laparoscopic lateral ovarian transposition before radiation treatment of Hodgkin disease. J. Am. Assoc. Gynecol. Laparosc. 4, 601-604 (1997).
53. Anderson B, LaPolla J. Turner D, Chapman G, Buller R: Ovarian transposition in cervical cancer. Gynecol. Oncol. 49, 206-214 (1993).
54. Bidzinski M, Lemieszczuk B, Zielinski J: Evaluation of the hormonal function and features of the ultrasound picture of transposed ovary in cervical cancer patients after surgery and pelvic irradiation. Eur. J. Gynaecal. Oncol. 14, 77-80 (1993).
55. Feeney DD, Moore DH, Look KY, Stehman FB, Sutton GP: The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol. Oncol. 56, 3-7 (1995).
56. Yarali H, Demirol A, Bukulmez O, Coskun F, Gurgan T: Laparoscopic h,igh lateral transposition of both ovaries before pelvic irradiation. J. Am. Assoc. Gynecol. Laparosc. 7, 237-239 (2000).
57. Swerdlow AJ, Jacobs PA, Marks A et al.: Fertility reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations. Br. J. Cancer 74, 291-296 (1996).
58. Chapman RM, Sutcliffe SB: Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood 58, 849-851 (1981).
59. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM: Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum. Reprod. 8, 2080-2087 (1993).
60. Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM: Fertility after treatment for Hodgkin's disease. Ann. Oncol. 13, 138-147 (2002).
61. Meduri G, Touraine P, Beau I et al.: Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J. Clin. Endocrinol. Metab. 88, 3491-3498 (2003).
62. Danforth DR, Arbogast LK, Friedman CI: Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil. Steril. 83(5), 1333-1338 (2005).
63. Tilly JL: Apoptosis, and ovarian function. Rev. Reprod. 1, 162-172 (1996).
64. Tilly JL: The molecular basis of ovarian cell death during germ cell attrition, follicular atresia, and luteolysis. Front. Biosci. 1, D1-D11 (1996).
65. Morita Y. Tilly JL: Oocyte apoptosis: like sand through an hourglass. Dev. Biol. 213. 1-17 (1999).
66. Tilly JL: Molecular and genetic basis of normal and toxicant-induced apoptosis in female germ cells. Toxicol. Lett. 102-103, 497-501 (1998).
67. Morita Y, Perez GI, Paris F et al.: Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med. 6, 1109-1114 (2000).